Oxidative stress, defective proteostasis and immunometabolic complications in critically ill patients

被引:1
|
作者
Galli, Francesco [1 ]
Bartolini, Desiree [1 ]
Ronco, Claudio [2 ]
机构
[1] Univ Perugia, Dept Pharmaceut Sci, Univ Pole Via Giochetto,Bldg B,2nd floor, I-06123 Perugia, Italy
[2] Univ Padua, San Bortolo Hosp Vicenza, Int Renal Res Inst Vicenza, Dept Med, Vicenza, Italy
关键词
critically ill patients; immune dysfunction; immunoresponse; inflammation; intensive care; multiorgan failure; oxidative stress; protein damage; proteostasis; proteostasis acute kidney injury; ACUTE LUNG INJURY; VITAMIN-E; AMINO-ACID; PROTEIN MODIFICATION; LIPID-PEROXIDATION; HYDROGEN-PEROXIDE; OXIDANT STRESS; TRACE-ELEMENTS; CELL-DEATH; SEPSIS;
D O I
10.1111/eci.14229
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Oxidative stress (OS) develops in critically ill patients as a metabolic consequence of the immunoinflammatory and degenerative processes of the tissues. These induce increased and/or dysregulated fluxes of reactive species enhancing their pro-oxidant activity and toxicity. At the same time, OS sustains its own inflammatory and immunometabolic pathogenesis, leading to a pervasive and vitious cycle of events that contribute to defective immunity, organ dysfunction and poor prognosis. Protein damage is a key player of these OS effects; it generates increased levels of protein oxidation products and misfolded proteins in both the cellular and extracellular environment, and contributes to forms DAMPs and other proteinaceous material to be removed by endocytosis and proteostasis processes of different cell types, as endothelial cells, tissue resident monocytes-macrophages and peripheral immune cells. An excess of OS and protein damage in critical illness can overwhelm such cellular processes ultimately interfering with systemic proteostasis, and consequently with innate immunity and cell death pathways of the tissues thus sustaining organ dysfunction mechanisms. Extracorporeal therapies based on biocompatible/bioactive membranes and new adsorption techniques may hold some potential in reducing the impact of OS on the defective proteostasis of patients with critical illness. These can help neutralizing reactive and toxic species, also removing solutes in a wide spectrum of molecular weights thus improving proteostasis and its immunometabolic corelates. Pharmacological therapy is also moving steps forward which could help to enhance the efficacy of extracorporeal treatments. This narrative review article explores the aspects behind the origin and pathogenic role of OS in intensive care and critically ill patients, with a focus on protein damage as a cause of impaired systemic proteostasis and immune dysfunction in critical illness. image
引用
收藏
页数:21
相关论文
共 50 条
  • [31] Analysis of oxidative stress-related markers in critically ill polytrauma patients: An observational prospective single-center study
    Sandesc, Mihai
    Rogobete, Alexandru Florin
    Bedreag, Ovidiu Horea
    Dinu, Anca
    Papurica, Marius
    Cradigati, Carmen Alina
    Sarandan, Mirela
    Popovici, Sonia Elena
    Bratu, Lavinia Melania
    Bratu, Tiberiu
    Stan, Adrian Tudor
    Sandesc, Dorel
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2018, 18 (02) : 191 - 197
  • [32] Gastrointestinal complications are associated with a poor outcome in non-critically ill pneumonia patients
    Huang, Chun-Ta
    Hong, Chun-Ming
    Tsai, Yi-Ju
    Sheng, Wang-Huei
    Yu, Chong-Jen
    BMC GASTROENTEROLOGY, 2020, 20 (01)
  • [33] Temporal variation of oxidant stress in critically ill patients
    Gunaydin, B.
    Sancak, B.
    Candan, S.
    Sariahmetoglu, M.
    Ozcagli, G.
    Tunctan, B.
    Cakici, I.
    Akcabay, M.
    MINERVA ANESTESIOLOGICA, 2007, 73 (05) : 261 - 266
  • [34] Iron Use in Critically Ill Patients: No More Stress?
    Rakonczay, Zoltan, Jr.
    CRITICAL CARE MEDICINE, 2016, 44 (03) : 638 - 639
  • [35] The effects of L-carnitine supplementation on inflammation, oxidative stress, and clinical outcomes in critically Ill patients with sepsis: a randomized, double-blind, controlled trial
    Keshani, Mahdi
    Alikiaii, Babak
    Babaei, Zahra
    Askari, Gholamreza
    Heidari, Zahra
    Sharma, Manoj
    Bagherniya, Mohammad
    NUTRITION JOURNAL, 2024, 23 (01)
  • [36] The effects of L-carnitine supplementation on inflammation, oxidative stress, and clinical outcomes in critically Ill patients with sepsis: a randomized, double-blind, controlled trial
    Mahdi Keshani
    Babak Alikiaii
    Zahra Babaei
    Gholamreza Askari
    Zahra Heidari
    Manoj Sharma
    Mohammad Bagherniya
    Nutrition Journal, 23
  • [37] Common Complications in the Critically Ill Patient
    To, Kathleen B.
    Napolitano, Lena M.
    SURGICAL CLINICS OF NORTH AMERICA, 2012, 92 (06) : 1519 - +
  • [38] LIPOLYTIC RESPONSE TO METABOLIC STRESS IN CRITICALLY ILL PATIENTS
    KLEIN, S
    PETERS, EJ
    SHANGRAW, RE
    WOLFE, RR
    CRITICAL CARE MEDICINE, 1991, 19 (06) : 776 - 779
  • [39] Pharmacokinetics of orally administered melatonin in critically ill patients
    Mistraletti, Giovanni
    Sabbatini, Giovanni
    Taverna, Martina
    Figini, Maria Adele
    Umbrello, Michele
    Magni, Paolo
    Ruscica, Massimiliano
    Dozio, Elena
    Esposti, Roberto
    DeMartini, Germana
    Fraschini, Franco
    Rezzani, Rita
    Reiter, Russel J.
    Iapichino, Gaetano
    JOURNAL OF PINEAL RESEARCH, 2010, 48 (02) : 142 - 147
  • [40] Dynamic neuroendocrine changes in critically ill patients with polytrauma
    Galusova, Andrea
    Pauliny, Matus
    Majek, Milan
    Mackova, Jaroslava
    Meskova, Milada
    Vlcek, Miroslav
    Imrich, Richard
    Penesova, Adela
    NEUROENDOCRINOLOGY LETTERS, 2015, 36 (05) : 498 - 503